Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moingeon

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Journal of Biotechnology|July 27, 2002
Strategies for designing vaccines eliciting Th1 responses in humansP Moingeon
Developments in Biologicals|December 18, 2004
Recombinant cancer vaccines based on viral vectorsP Moingeon
Allergy|June 24, 2006
Sublingual immunotherapy: from biological extracts to recombinant allergensP Moingeon
Vaccine|February 13, 2001
Cancer vaccinesP Moingeon
Annales Pharmaceutiques Francaises|February 2, 2021
[Applications of artificial intelligence to new drug development]P Moingeon
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 24, 2014
The specifics of allergen recognition by CD4(+) T lymphocytes at the epitope levelP Moingeon
Cell Biology and Toxicology|August 14, 2001
Cancer vaccines based on dendritic cells loaded with tumor-associated antigensN Burdin, P Moingeon
Vaccine|August 3, 2001
Towards the rational design of Th1 adjuvantsP Moingeon, J Haensler, A Lindberg
Research Communications in Chemical Pathology and Pharmacology|January 1, 1983
Muscarinic cholinergic receptors on circulating human lymphocytes: evidence for a particulate binding siteJ M Bidart, P Moingeon, C Bohuon
International Immunology|August 1, 1992
Characterization of Fc epsilon RI gamma in human natural killer cellsP Moingeon, J L Lucich, E L Reinherz
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Journal of Biotechnology|July 27, 2002
Strategies for designing vaccines eliciting Th1 responses in humansP Moingeon
Developments in Biologicals|December 18, 2004
Recombinant cancer vaccines based on viral vectorsP Moingeon
Allergy|June 24, 2006
Sublingual immunotherapy: from biological extracts to recombinant allergensP Moingeon
Vaccine|February 13, 2001
Cancer vaccinesP Moingeon
Annales Pharmaceutiques Francaises|February 2, 2021
[Applications of artificial intelligence to new drug development]P Moingeon
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 24, 2014
The specifics of allergen recognition by CD4(+) T lymphocytes at the epitope levelP Moingeon
Cell Biology and Toxicology|August 14, 2001
Cancer vaccines based on dendritic cells loaded with tumor-associated antigensN Burdin, P Moingeon
Vaccine|August 3, 2001
Towards the rational design of Th1 adjuvantsP Moingeon, J Haensler, A Lindberg
Research Communications in Chemical Pathology and Pharmacology|January 1, 1983
Muscarinic cholinergic receptors on circulating human lymphocytes: evidence for a particulate binding siteJ M Bidart, P Moingeon, C Bohuon
International Immunology|August 1, 1992
Characterization of Fc epsilon RI gamma in human natural killer cellsP Moingeon, J L Lucich, E L Reinherz
Pageof 9